Pharmaceutical Industry Information Portal

EpiVacCorona-N vaccine to be released for use in near future

The EpiVacCorona-N coronavirus vaccine will be released into civil circulation in the near future, Tatiana Nepomnyashchikh, a deputy head of the Vector State Research Center of Virology and Biotechnology, told TASS on Thursday.

EpiVacCorona-N has not yet been released into the stream of commerce because we received the authorization only on Thursday. As soon as our industrial partners manufacture the series, the health regulator will give authorization for the release into the civil circulation. It will be in the near future, she said on the sidelines of the Eastern Economic Forum (EEF).

The EpiVacCorona-N coronavirus vaccine developed by the Vector Center was registered with the Russian health ministry last Thursday.

The Center’s chief, Rinat Maksyutov, said earlier that were are no principal differences between the EpiVacCorona and EpiVacCorona-N vaccines. According to Maksyutov, the vaccines differ by technological specifics of the production process. However, new clinical tests were needed all the same.


Expert Articles